The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines.
 
Timothy I Shaw
Patents, Royalties, Other Intellectual Property - TImothy Shaw reports a patent application in CAR T cell therapy US20220267425A1.; Timothy Shaw reports a pending patent application on software for survival analysis.
 
Darwin Chang
No Relationships to Disclose
 
Alyssa N Obermayer
No Relationships to Disclose
 
Dale Hedges
No Relationships to Disclose
 
Aik-choon Tan
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Margaret Elena Gatti-Mays
Honoraria - Oncology Learning Network
Consulting or Advisory Role - GE HealthCare; SeaGen
 
Aakrosh Ratan
No Relationships to Disclose
 
Martin McCarter
Research Funding - Merck; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Application No. 63/303,915. METHOD FOR TREATING MALIGNANT MELANOMA; International Patent Application No. PCT/US2020/052790 Title: ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS
Other Relationship - Debbies Dream Foundation
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Bristol Meyer Squibb; Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
Other Relationship - M2Gen
 
Howard Colman
Consulting or Advisory Role - Adastra Pharmaceuticals; Best Doctors, Inc; Bristol-Myers Squibb; Novocure; Orbus Therapeutics; PPD/Chimerix; Regeneron
Research Funding - Abbvie (Inst); Array BioPharma (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); DNAtrix (Inst); Erasca, Inc (Inst); FORMA Therapeutics (Inst); Global Coalition for Adaptive Research (Inst); Kadmon (Inst); Merck (Inst); Nuvation Bio (Inst); Orbus Therapeutics (Inst); Samus Therapeutics (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; FORMA Therapeutics; Karyopharm Therapeutics; Orbus Therapeutics
 
Igor Puzanov
Stock and Other Ownership Interests - Celldex; Celldex (I)
Consulting or Advisory Role - Amgen; Iovance Biotherapeutics; Merck; Nektar; Nouscom; Oncorus; Roche; Seneca Therapeutics
 
Susanne M. Arnold
Consulting or Advisory Role - Penn State Cancer Institute
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Ellipses Pharma (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Kinnate Biopharma (Inst); Kura Oncology (Inst); LabCorp (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst); Regeneron (Inst); Syneos Health (Inst)
 
Michelle L. Churchman
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Dragonfly Therapeutics; Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; Immatics
Research Funding - Genentech
 
William S. Dalton
Employment - M2Gen
Stock and Other Ownership Interests - M2Gen
Patents, Royalties, Other Intellectual Property - I am the inventor of 11 patents owned by the Moffitt Cancer Center. The patents are in two areas: 1. new target discoveries in cancers 2. new information systems for health and molecular data
 
George J. Weiner
No Relationships to Disclose
 
Jose Conejo-Garcia
Patents, Royalties, Other Intellectual Property - patent application in CAR T cell therapy
 
Paulo Rodriguez
No Relationships to Disclose
 
Ahmad A. Tarhini
Consulting or Advisory Role - AstraZeneca; Bayer; BioNTech; Bristol-Myers Squibb; Clinigen Group; ConcertAI; Eisai; Genentech/Roche; Instil Bio; Merck; Novartis; Partner Therapeutics; Sanofi/Regeneron
Research Funding - Acrotech Biopharma (Inst); Agenus (Inst); Agenus (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Genentech/Roche (Inst); InflaRx (Inst); Merck (Inst); OncoSec (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst); Scholar Rock (Inst)